Trade SANA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Sana Biotechnology, Inc. (SANA) is trading at US$4.03, down 1.59% today as of Aug 28, 11:18 EDT. The company has a market capitalisation of US$1.17B. Over the past 52 weeks, SANA has traded between US$2.61 and US$6.55. On Syfe you can trade SANA with $0 commission and add it to your watchlist.
| Previous close | US$4.09 |
|---|---|
| Market cap | US$1.17B |
| 52-week range | US$2.61 – US$6.55 |
| Volume | 1.69M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Year: 2021
Sana Biotechnology Raises $69 Million Through ATM Equity Offering
May 15, 1:43 PM · MT Newswires
-- Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16
May 11, 8:13 PM · MT Newswires
Sana Biotechnology, Inc. (SANA) stock is trading at US$4.03, -1.59% from the previous close of US$4.09.
The market cap for Sana Biotechnology, Inc. (SANA) stock is approximately US$1.17B.
The 52-week high for Sana Biotechnology, Inc. (SANA) stock is US$6.55.
The 52-week low for Sana Biotechnology, Inc. (SANA) stock is US$2.61.
Sana Biotechnology, Inc. (SANA) does not currently pay a dividend.
Stay on top of SANA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
